GPGünther Paesold

Günther Paesold

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Günther Paesold has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Cell-seeded polyurethane-fibrin structures – A possible system for intervertebral disc regeneration

    by C Mauth, E Bono, S Haa, G Paesold, H Wiese, G Maier, N Boos, U Graf-Hausner

    Nowadays, intervertebral disc (IVD) degeneration is one of the principal causes of low back pain involving high expense within the health care system. The long-term goal is the development of a medical treatment modality focused on a more biological regeneration of the inner nucleus pulposus (NP). Hence, interest in the endoscopic implantation of an injectable material took center stage in the recent past. We report on the development of a novel polyurethane (PU) scaffold as a mechanically stable carrier system for the reimplantation of expanded autologous IVD-derived cells (disc cells) to stimulate regenerative processes and restore the chondrocyte-like tissue within the NP. Primary human disc cells were seeded into newly developed PU spheroids which were subsequently encapsulated in fibrin hydrogel. The study aims to analyze adhesion properties, proliferation capacity and phenotypic characterization of these cells. Polymerase chain reaction was carried out to detect the expression of genes specifically expressed by native IVD cells. Biochemical analyses showed an increased DNA content, and a progressive enhancement of total collagen and glycosaminoglycans (GAG) was observed during cell culture. The results suggest the synthesis of an appropriate extracellular matrix as well as a stable mRNA expression of chondrogenic and/or NP specific markers. In conclusion, the data presented indicate an alternative medical approach to current treatment options of degenerated IVD tissue.


  • Age-Related Changes of the Spine

    by Atul Sukthankar, Andreas G. Nerlich, Günther Paesold


  • Analysis of Tissue Distribution of TNF‐α, TNF‐α‐Receptors, and the Activating TNF‐α–Converting Enzyme Suggests Activation of the TNF‐α System in the Aging Intervertebral Disc

    by Beatrice E. Bachmeier, Andreas G. Nerlich, Christoph Weiler, Günther Paesold, Marianne Jochum, Norbert Boos

    We immunohistochemically analyzed the expression and localization of TNF‐α, its receptors TNF‐RI and ‐RII, and the TNF‐α‐activating enzyme TACE in human autopsy (n= 63) and surgical (n= 35) lumbar intervertebral disc samples. In parallel, the TNF‐α‐mRNA was quantified by reverse transcriptase‐polymerase chain reaction (RT‐PCR). All samples were morphometrically evaluated for the proportion of positively labeled cells in the different anatomical regions of the disc. We detected a significant and comparable expression of all four parameters beginning in young adult age (c. 18 years ) and being most extensive in the nucleus pulposus. This level was slightly reduced in older age discs. The annulus fibrosus contained significantly less labeled cells. In accord, the number of TNF‐α‐transcripts was elevated in most cases with immunohistochemical TNF‐α expression. We provide clear evidence that TNF‐α is expressed in discs of increasing age, which correlates with histomorphological signs of disc degeneration. In consequence, TNF‐α seems to be activated (by the converting enzyme TACE) and biologically active through its receptors in human lumbar disc tissue.


  • Open Access

    Biological treatment strategies for disc degeneration: potentials and shortcomings

    by Günther Paesold, Andreas G. Nerlich, Norbert Boos

    Recent advances in molecular biology, cell biology and material sciences have opened a new emerging field of techniques for the treatment of musculoskeletal disorders. These new treatment modalities aim for biological repair of the affected tissues by introducing cell-based tissue replacements, genetic modifications of resident cells or a combination thereof. So far, these techniques have been successfully applied to various tissues such as bone and cartilage. However, application of these treatment modalities to cure intervertebral disc degeneration is in its very early stages and mostly limited to experimental studies in vitro or in animal studies. We will discuss the potential and possible shortcomings of current approaches to biologically cure disc degeneration by gene therapy or tissue engineering. Despite the increasing number of studies examining the therapeutic potential of biological treatment strategies, a practicable solution to routinely cure disc degeneration might not be available in the near future. However, knowledge gained from these attempts might be applied in a foreseeable future to cure the low back pain that often accompanies disc degeneration and therefore be beneficial for the patient.


  • ChronicSalmonella entericaSerovar Typhimurium-Induced Colitis and Cholangitis in Streptomycin-PretreatedNramp1+/+Mice

    by Bärbel Stecher, Günther Paesold, Manja Barthel, Marcus Kremer, Jonathan Jantsch, Thomas Stallmach, Mathias Heikenwalder, Wolf-Dietrich Hardt

    Salmonella entericasubspecies 1 serovar Typhimurium is an enteric bacterial pathogen infecting a broad range of hosts. In susceptibleNramp1−/−(Slc11α1−/−) mice, serovar Typhimurium cannot efficiently colonize the intestine but causes a systemic typhoid-like infection. However, after pretreatment with streptomycin, these susceptible (C57BL/6 and BALB/c) mice develop acute serovar Typhimurium-induced colitis (M. Barthel et al., Infect. Immun.71:2839-2858, 2003). It was not clear whether resistantNramp1+/+(Slc11α1+/+) mouse strains would similarly develop colitis. Here we compared serovar Typhimurium infection in streptomycin-pretreated susceptible (C57BL/6) and resistant (DBA/2 and 129Sv/Ev) mouse strains: We found that acute colitis (days 1 and 3 postinfection) is strikingly similar in susceptible and resistant mice. In 129Sv/Ev mice we followed the serovar Typhimurium infection for as long as 6 weeks. After the initial phase of acute colitis, these animals developed chronic crypt-destructive colitis, including ulceration, crypt abscesses, pronounced mucosal and submucosal infiltrates, overshooting regeneration of the epithelium, and crypt branching. Moreover, we observed inflammation of the gall duct epithelium (cholangitis) in the 129Sv/Ev mice between days 14 and 43 of infection. Cholangitis was not attributable to side effects of the streptomycin treatment. Furthermore, chronic infection of 129Sv/Ev mice in a typhoid fever model did not lead to cholangitis. We propose that streptomycin-pretreated 129Sv/Ev mice provide a robust murine model for chronic enteric salmonellosis including complications such as cholangitis.


  • The Course of Macroscopic Degeneration in the Human Lumbar Intervertebral Disc

    by Mathias Haefeli, Fabian Kalberer, Daniel Saegesser, Andreas G. Nerlich, Norbert Boos, Günther Paesold

    Assessment of age-related macroscopic changes in human lumbar intervertebral discs (IVD) and vertebral bodies. To determine the sequence of macroscopic changes during aging/degeneration. Descriptive studies on macroscopic alterations of the IVD during aging/degeneration are readily available, but quantitative analyses are sparse. A total of 248 mid-/parasagittal sections of lumbar IVD and vertebral bodies from 41 routine autopsies (range, 7 months to 88 years) were semiquantitatively assessed for macroscopic parameters and correlated with age. Nuclear fibrous transformation, anular disorganization, endplate, and vertebral body alterations progress predominantly in the first two and in the fifth to seventh decades. In the third and fourth decade, little progression occurs. Nuclear clefts and anular tears appear later, mostly starting in the second decade, with clefts preceding tear formation. Radial and concentric tears develop similarly over time, whereas rim lesions mostly develop after the sixth decade. Significant differences are observed between upper and lower lumbar spine. Our data show that fibrous nuclear transformation during aging/degeneration precedes cleft formation. The temporal sequence suggests a strong correlation of cleft and tears formation starting with clefts in the second decade. Our results support the hypothesis that disc degeneration starts in the nucleus. Extensive macroscopic alterations already apparent in the second life decade present a challenge to any tissue engineering and repair attempt.


  • Point of View

    by Günther Paesold, Norbert Boos

  • Open Access

    Modulation of chloride secretory responses and barrier function of intestinal epithelial cells by the Salmonella effector protein SigD

    by Lone S. Bertelsen, Günther Paesold, Sandra L. Marcus, Brett B. Finlay, Lars Eckmann, Kim E. Barrett

    The Salmonella effector protein SigD is an inositol phosphate phosphatase that inhibits phosphatidylinositol 3-kinase-dependent signaling. Because epidermal growth factor (EGF) inhibits chloride secretion via phosphatidylinositol 3-kinase, we explored whether Salmonella infection might modify the inhibitory effect of EGF. As expected, EGF inhibited chloride secretion induced by carbachol in T84 epithelial cells. Infection with wild-type (WT) but not sigD− mutant S. typhimurium SL1344 decreased CCh-stimulated chloride secretion. Moreover, WT but not sigD− Salmonella reduced the inhibitory effect of EGF on carbachol-stimulated chloride secretion. Complementation of sigD restored the ability of mutant Salmonella to reverse the inhibitory effect of EGF. EGF-induced EGF receptor phosphorylation was similar in cells infected with either WT or mutant Salmonella, and neither WT nor sigD − Salmonella altered recruitment of the p85 subunit of phosphatidylinositol 3-kinase to EGF receptor, implying that SigD acts downstream of these signaling events. Furthermore, transepithelial resistance fell more rapidly in cells infected with WT vs. sigD − Salmonella, indicating an early role for SigD in reducing barrier function, perhaps via activation of protein kinase C. We conclude that the Salmonella bacterial effector protein SigD may play critical roles in the pathogenesis of disease caused by this microorganism.


  • Open Access

    Genes in theSalmonellapathogenicity island 2 and theSalmonellavirulence plasmid are essential forSalmonella-induced apoptosis in intestinal epithelial cells

    by Günther Paesold, Donald G. Guiney, Lars Eckmann, Martin F. Kagnoff

    Intestinal epithelial cells are an important site of the host's interaction with enteroinvasive bacteria. Genes in the chromosomally encoded Salmonella pathogenicity island 2 (SPI 2) that encodes a t...


  • Ubiquitous production of macrophage migration inhibitory factor by human gastric and intestinal epithelium

    by Christian Maaser, Lars Eckmann, Günther Paesold, Hyun S. Kim, Martin F. Kagnoff